Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H V Marquart

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Genes and Immunity|January 29, 2011
Complement factor H deficiency and endocapillary glomerulonephritis due to paternal isodisomy and a novel factor H mutationL Schejbel, I M Schmidt, M Kirchhoff, et al.
Clinical and Experimental Immunology|July 1, 1995
Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE)H V Marquart, A Svendsen, J M Rasmussen, et al.
Leukemia|June 18, 2011
Immunophenotype-defined sub-populations are common at diagnosis in childhood B-cell precursor acute lymphoblastic leukemiaN F Øbro, H V Marquart, H O Madsen, et al.
Leukemia|August 19, 2017
Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemiaN Toft, H Birgens, J Abrahamsson, et al.
Leukemia|October 16, 2019
T-cell acute lymphoblastic leukemia in patients 1-45 years treated with the pediatric NOPHO ALL2008 protocolP Quist-Paulsen, N Toft, M Heyman, et al.
Leukemia|December 16, 2018
Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemiaS Modvig, H O Madsen, S M Siitonen, et al.
Leukemia|December 12, 2019
Correction: Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemiaS Modvig, H O Madsen, S M Siitonen, et al.
Leukemia|December 15, 2020
Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter settingS Modvig, H Hallböök, H O Madsen, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Genes and Immunity|January 29, 2011
Complement factor H deficiency and endocapillary glomerulonephritis due to paternal isodisomy and a novel factor H mutationL Schejbel, I M Schmidt, M Kirchhoff, et al.
Clinical and Experimental Immunology|July 1, 1995
Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE)H V Marquart, A Svendsen, J M Rasmussen, et al.
Leukemia|June 18, 2011
Immunophenotype-defined sub-populations are common at diagnosis in childhood B-cell precursor acute lymphoblastic leukemiaN F Øbro, H V Marquart, H O Madsen, et al.
Leukemia|August 19, 2017
Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemiaN Toft, H Birgens, J Abrahamsson, et al.
Leukemia|October 16, 2019
T-cell acute lymphoblastic leukemia in patients 1-45 years treated with the pediatric NOPHO ALL2008 protocolP Quist-Paulsen, N Toft, M Heyman, et al.
Leukemia|December 16, 2018
Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemiaS Modvig, H O Madsen, S M Siitonen, et al.
Leukemia|December 12, 2019
Correction: Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemiaS Modvig, H O Madsen, S M Siitonen, et al.
Leukemia|December 15, 2020
Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter settingS Modvig, H Hallböök, H O Madsen, et al.
Pageof 2